TSS
NMTR

Two Sigma Securities’s 9 Meters Biopharma NMTR Stock Holding History

Two Sigma Securities’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,844
Closed -$9.3K – 3659
2023
Q2 		$9.3K Buy
+13,844
New +$12.2K ﹤0.01% 2607
2022
Q4 		– Sell
-1,511
Closed -$6K – 3448
2022
Q3 		$6K Sell
1,511
-1,132
-43% -$5.61K ﹤0.01% 2474
2022
Q2 		$14K Buy
+2,643
New +$24.9K ﹤0.01% 2009
2021
Q4 		– Sell
-1,242
Closed -$32K – 2179
2021
Q3 		$32K Buy
+1,242
New +$29.3K ﹤0.01% 1428
2018
Q1 		– Sell
-92
Closed -$11K – 3035
2017
Q4 		$11K Buy
+92
New +$11.8K ﹤0.01% 1673

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Two Sigma Securities's NMTR Position: Q3 2023 in Review

Two Sigma Securities sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 13,844 shares — an estimated $9.3K sold.

Two Sigma Securities first reported a position in NMTR in Q4 2017 and held it in 5 quarters. The position peaked at $32K in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Two Sigma Securities reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Securities sold 13,844 9 Meters Biopharma shares in Q3 2023, an estimated $9.3K.
  • Two Sigma Securities first reported a position in 9 Meters Biopharma in Q4 2017 and held it in 5 quarters.
  • Two Sigma Securities's 9 Meters Biopharma position peaked at $32K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.